Skip navigation

Strengthen Compliance Programs to Combat Anti-Kickback, Off-Label, Fraud and Abuse Risks

December 4-5, 2018
  • Philadelphia, PA

With recent Anti-Kickback and False Claim Act enforcement actions, it is critical for manufacturers to ensure compliant business practices in complex managed markets. CBI’s 3rd Annual Managed Markets Compliance Congress returns in 2018 to convene leading industry experts in compliance, contracting and managed markets to discuss key concerns related to value-based contracting, off-label compliance, patient services, price reporting and much more.

Gain Critical Insights Facing Compliance Teams Working in Managed Markets:

  • Explore compliance risks associated with specialty pharmacy
    arrangements — Anti-kickback risks, off-label, privacy and
    government pricing
  • Consider risk-based management practices to monitor focus
    arrangements and fraud throughout the contracting process
  • Examine enforcement trends, risk assessments and best practices
    to set up compliant interactions with Patient Services Programs
  • Review anti-kickback risks associated with payments to
    the federal government
  • Identify the most pressing areas of off-label risks associated
    with HCP interactions and promotional activities
  • Monitor pricing compliance through proactive management
    of network size and 340B contracts
  • Promote coordination between legal, compliance and
    contracting teams to optimize the contracting process

ATTENDEE ACCLAIM FOR CBI’S COMPLIANCE SERIES:

Best conference I have attended. All material was very relevant, speakers were on point, sharp and insightful. Timing allocation was also excellent.

Senior Compliance Manager, Johnson & Johnson

Great conference with speakers who are industry leaders. Smaller group allowed for more open dialogue and sharing of information.

Senior Analyst Compliance, Bayer Healthcare

I look forward to attending CBI for the candid discussions and presentations regarding the pharmaceutical compliance environment.

Government Contracting & Pricing Compliance Officer,
Johnson & Johnson

Managed Markets Compliance Congress

Strengthen Compliance Programs to Combat Anti-Kickback, Off-Label, Fraud and Abuse Risks

With recent Anti-Kickback and False Claim Act enforcement actions, it is critical for manufacturers to ensure compliant business practices in complex managed markets. CBI’s 3rd Annual Managed Markets Compliance Congress returns in 2018 to convene leading industry experts in compliance, contracting and managed markets to discuss key concerns related to value-based contracting, off-label compliance, patient services, price reporting and much more.

Gain Critical Insights Facing Compliance Teams Working in Managed Markets:

  • Explore compliance risks associated with specialty pharmacy
    arrangements — Anti-kickback risks, off-label, privacy and
    government pricing
  • Consider risk-based management practices to monitor focus
    arrangements and fraud throughout the contracting process
  • Examine enforcement trends, risk assessments and best practices
    to set up compliant interactions with Patient Services Programs
  • Review anti-kickback risks associated with payments to
    the federal government
  • Identify the most pressing areas of off-label risks associated
    with HCP interactions and promotional activities
  • Monitor pricing compliance through proactive management
    of network size and 340B contracts
  • Promote coordination between legal, compliance and
    contracting teams to optimize the contracting process

ATTENDEE ACCLAIM FOR CBI’S COMPLIANCE SERIES:

Best conference I have attended. All material was very relevant, speakers were on point, sharp and insightful. Timing allocation was also excellent.

Senior Compliance Manager, Johnson & Johnson

Great conference with speakers who are industry leaders. Smaller group allowed for more open dialogue and sharing of information.

Senior Analyst Compliance, Bayer Healthcare

I look forward to attending CBI for the candid discussions and presentations regarding the pharmaceutical compliance environment.

Government Contracting & Pricing Compliance Officer,
Johnson & Johnson